Enrolling

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

J3K-MC-KIAB -

The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better.

Enter your city or zip code to find the nearest site

Trial Summary

Age Range
18 - 55 years
Conditions the trial is for
Multiple sclerosis
What the trial is testing?
LY3541860
Could I receive a Placebo?
Yes
Enrollment Goal
200
Trial Dates
Mar 19, 2024 - Aug 2028
How long will I be in the trial?
The study will last about 9 months with additional 6 months follow-up.
Trial Phase
II

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have multiple sclerosis that gets better and worse over time (relapsing multiple sclerosis)

  • Have had recent relapses

Participants Must Not:

  • Have other types of multiple sclerosis like progressive multiple sclerosis

  • Be limited in their ability to perform their daily activities

  • Have been treated with some other common multiple sclerosis treatment

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources